293 related articles for article (PubMed ID: 9520940)
1. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease.
Olvera M; Harris S; Amezcua CA; McCourty A; Rezk S; Koo C; Felix JC; Brynes RK
Mod Pathol; 2001 Oct; 14(10):1036-42. PubMed ID: 11598175
[TBL] [Abstract][Full Text] [Related]
3. The expression of Cdk inhibitors p27kip1 and p57kip2 in mouse placenta and human choriocarcinoma JEG-3 cells.
Kim ST; Lee SK; Gye MC
Placenta; 2005 Jan; 26(1):73-80. PubMed ID: 15664414
[TBL] [Abstract][Full Text] [Related]
4. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
5. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2.
Castrillon DH; Sun D; Weremowicz S; Fisher RA; Crum CP; Genest DR
Am J Surg Pathol; 2001 Oct; 25(10):1225-30. PubMed ID: 11688455
[TBL] [Abstract][Full Text] [Related]
6. Expression of the human P2Y6 nucleotide receptor in normal placenta and gestational trophoblastic disease.
Somers GR; Bradbury R; Trute L; Conigrave A; Venter DJ
Lab Invest; 1999 Feb; 79(2):131-9. PubMed ID: 10068202
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
[TBL] [Abstract][Full Text] [Related]
8. Genetic origin and imprinting in hydatidiform moles. Comparison between DNA polymorphism analysis and immunoreactivity of p57KIP2.
Kihara M; Matsui H; Seki K; Nagai Y; Wake N; Sekiya S
J Reprod Med; 2005 May; 50(5):307-12. PubMed ID: 15971478
[TBL] [Abstract][Full Text] [Related]
9. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles.
Jun SY; Ro JY; Kim KR
Histopathology; 2003 Jul; 43(1):17-25. PubMed ID: 12823708
[TBL] [Abstract][Full Text] [Related]
10. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
Shih IM; Kurman RJ
Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
[TBL] [Abstract][Full Text] [Related]
11. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
12. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification.
Genest DR; Dorfman DM; Castrillon DH
J Reprod Med; 2002 May; 47(5):342-6. PubMed ID: 12063872
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles.
Fukunaga M
Hum Pathol; 2002 Dec; 33(12):1188-92. PubMed ID: 12514787
[TBL] [Abstract][Full Text] [Related]
14. Low and maternal-specific expression of p57KIP2 in hydatidiform mole and its clinical implication.
Xiong Y; Cao Y; Li H
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(2):121-2, 157. PubMed ID: 12658751
[TBL] [Abstract][Full Text] [Related]
15. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
16. Relaxation of imprinting in trophoblastic disease.
Ariel I; Lustig O; Oyer CE; Elkin M; Gonik B; Rachmilewitz J; Biran H; Goshen R; de Groot N; Hochberg A
Gynecol Oncol; 1994 May; 53(2):212-9. PubMed ID: 8188082
[TBL] [Abstract][Full Text] [Related]
17. P57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions.
Hoffner L; Dunn J; Esposito N; Macpherson T; Surti U
Hum Pathol; 2008 Jan; 39(1):63-72. PubMed ID: 17904617
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical characterization of p57Kip2 expression in tetraploid hydropic placentas.
Fukunaga M
Arch Pathol Lab Med; 2004 Aug; 128(8):897-900. PubMed ID: 15270611
[TBL] [Abstract][Full Text] [Related]
19. p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses.
Merchant SH; Amin MB; Viswanatha DS; Malhotra RK; Moehlenkamp C; Joste NE
Hum Pathol; 2005 Feb; 36(2):180-6. PubMed ID: 15754295
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of p27 in comparison to p57 in differentiation between different gestational trophoblastic diseases.
Abdou A; Kandil M; El-Wahed MA; Shabaan M; El-Sharkawy M
Fetal Pediatr Pathol; 2013 Dec; 32(6):395-411. PubMed ID: 23438793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
